All Roll Calls
Yes: 298 • No: 0
Sponsored By: Cole Hefner, Bryan Hughes (Republican), Jared Patterson
Signed by Governor
Personalized for You
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
5 provisions identified: 5 benefits, 0 costs, 0 mixed.
For contracts made or renewed beginning September 1, 2025, insurers and pharmacy benefit managers must provide pharmacies secure online access to contracts, addenda, and provider manuals, including updates. Contracts must include referenced documents as part of the contract or an attachment, and state all financial terms, including payment rates and calculation methods. A separate fee schedule must list service payments, use a method based on a published schedule, or otherwise make payment amounts clear. Contracts must state that Texas Insurance Code Chapter 1369 and the insurance commissioner's related rules apply. No contract-related fee, including an application or participation fee, can be charged before the full proposed contract identifies the network and discloses applicable financial terms.
The group-number rule applies to covered Texas health plans delivered, issued for delivery, or renewed beginning January 1, 2026. A covered plan's identification-card group number can be assigned only to people enrolled in plans covered by this law. Plans already in force remain under prior law until the new rule applies. This rule does not change household eligibility, benefits, or payment amounts.
For contracts made or renewed beginning September 1, 2025, insurers and pharmacy benefit managers cannot force pharmacies or pharmacists to join a network. They cannot make joining one network depend on joining another. They also cannot penalize pharmacies or pharmacists for refusing to join. These rules protect pharmacy choice, not a household's right to use any pharmacy.
For contracts made or renewed beginning September 1, 2025, adverse material changes during the contract term require mutual agreement and the pharmacy's written approval. They cannot start before the 120th day after approval. A clear notice must let pharmacies refuse without changing existing terms or participation in another network; without it, an agreed change is void. Other changes require portal posting and email notice at least 90 days ahead, with a portal link, applicable pharmacy identifier, and description showing what changes. Silence by the 31st day after notice can count as approval for those other changes. These rules exclude changes required by state or federal law or rule, and indefinite contracts with no stated or automatic renewal period or event that end only by one party notifying the other.
For contracts made or renewed beginning September 1, 2025, Texas law generally bars insurers and pharmacy benefit managers from reducing claims already approved for payment. They can recover drug costs and dispensing fees for fraud, duplicate payments, or substantive errors—not clerical or recordkeeping errors—that caused a wrong drug or dose. For clerical errors causing overpayments, they can recover only the dispensing fee, not the drug cost. They cannot use results from sampled claims to calculate recovery amounts across other claims. These protections apply to pharmacy payments, not household benefit amounts.
Cole Hefner
House
Bryan Hughes
Republican • Senate
Jared Patterson
House
César Blanco
Democratic • Senate
Kevin Sparks
Republican • Senate
All Roll Calls
Yes: 298 • No: 0
House vote • 5/13/2025
Record vote
Yes: 140 • No: 0
House vote • 5/12/2025
Record vote
Yes: 142 • No: 0
Senate vote • 4/24/2025
Record vote
Yes: 0 • No: 0
Senate vote • 4/24/2025
Record vote
Yes: 0 • No: 0
House vote • Unknown
Committee vote: Insurance
Yes: 7 • No: 0
Senate vote • Unknown
Committee vote: Health & Human Services
Yes: 9 • No: 0
Effective on 9/1/25
Signed by the Governor
Sent to the Governor
Signed in the House
Signed in the Senate
Reported enrolled
House passage reported
Statement(s) of vote recorded in Journal
Record vote (RV#2322)
Passed
Read 3rd time
Statement(s) of vote recorded in Journal
Record vote (RV#2168)
Passed to 3rd reading
Read 2nd time
Laid out in lieu of companion (CSHB 3317)
Committee report sent to Calendars
Committee report distributed
Comte report filed with Committee Coordinator
Reported favorably w/o amendment(s)
Considered in public hearing
Referred to Insurance
Read first time
Received from the Senate
Reported engrossed
Engrossed
Enrolled
House Committee Report
Introduced
Senate Committee Report
SB 2111, Relating to legal representation of indigent persons in this state and to proceedings before a magistrate including the appointment of counsel for an indigent defendant.
SB 1838, Relating to the appointment of attorneys ad litem and the compensation of certain attorneys ad litem in suits affecting the parent-child relationship filed by a governmental entity.
SB 3, Relating to the regulation of products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and permits; imposing fees; creating criminal offenses; authorizing an administrative penalty.
SB 2878, Relating to the operation and administration of and practices and procedures related to proceedings in the judicial branch of state government, including court security, court documents and arrest warrants, document delivery, juvenile boards, constitutional amendment election challenges, mandatory expunction for certain persons, record retention, and youth diversion; increasing a criminal penalty; authorizing fees.
SB 646, Relating to repayment of certain mental health professional education loans.
HB 4325, Relating to civil liability for prohibited barratry.